Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Luminescent Probe Measures Immune Cell Activity in Real Time

By LabMedica International staff writers
Posted on 09 Oct 2025

The human immune system plays a vital role in defending against disease, but its activity must be precisely monitored to ensure effective treatment in cancer therapy, autoimmune disorders, and organ transplants. More...

Current methods cannot measure immune cell function directly and in real time, making it difficult to tailor immunosuppressive or immunotherapy regimens to individual patients. Now, a new luminescent probe offers a way to observe immune activity as it happens, enabling highly personalized medical interventions and advancing precision medicine.

Researchers from the University of Granada (Granada, Spain) and Mount Sinai Hospital (New York, NY, USA) have developed GLed, a groundbreaking molecular probe that can monitor immune system activity live and with exceptional sensitivity. Acting as a “molecular beacon,” the probe lights up upon detecting glutathione, a key antioxidant molecule that signals cellular activity levels. Its most distinctive feature is reversibility—it switches on and off dynamically—allowing scientists to track real-time fluctuations in T cell function with unmatched speed and precision.

In a study published in Advanced Science, the researchers used GLed to investigate how glutathione production is regulated during T cell activation. Results revealed that the enzyme gamma-glutamyl cysteine ligase (GCL) is solely responsible for producing new glutathione in active human T cells. When GCL was inhibited, T cells lost their ability to multiply and secrete inflammatory molecules, demonstrating the enzyme’s essential role in immune response regulation.

Researchers also applied GLed to assess the effects of commonly used immunosuppressive drugs such as prednisone and tacrolimus. The probe showed that these drugs reduce GCL activity in proportion to their immunosuppressive strength, providing the first direct and functional measurement of immune suppression in living cells. This capability could allow clinicians to adjust drug dosages precisely for each patient, improving treatment safety and efficacy.

In addition to its clinical utility, GLed offers powerful new possibilities for basic research in immunology, inflammation, and oncology. Its use in functional monitoring may transform how immune-related diseases are studied and treated. Over time, integrating this probe into clinical settings could revolutionize transplant medicine and immunotherapy by making immune function tracking as routine as blood tests.

Related Links:
University of Granada
Mount Sinai Hospital 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
New
Slide Scanner System
NanoZoomer S540MD
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

AI in Cancer Diagnosis and Molecular Testing Takes Center Stage at AMP 2026

Artificial intelligence (AI) is increasingly being integrated into molecular diagnostics, offering new approaches to interpreting complex genetic information, classifying cancers, and optimizing laboratory testing.... Read more

Microbiology

view channel
Image: Graphical Abstract (Matthew A Butzler, Jennifer L Reed, Alaina M Olson, et al. Development of a Rapid Automated Point-of-Care Test for Mycobacterium tuberculosis Detection from Tongue Swabs and Sputum Specimens on the DASH® Rapid PCR System, Open Forum Infectious Diseases, 2026; https://doi.org/10.1093/ofid/ofag706)

Rapid Point-of-Care Test Detects Tuberculosis from Tongue Swab and Sputum

Tuberculosis remains a major infectious disease challenge, particularly in regions with limited access to diagnostic testing and treatment. Diagnosis can be time-consuming, and collecting sputum samples... Read more

Pathology

view channel
Image Credit: Adobe Stock

New Training Approach Helps AI Distinguish Neighboring Cells in Tissue

Artificial intelligence (AI) can assist with identifying cells in digital pathology images, but densely packed tissue remains difficult to analyze. Neighboring cells may be merged, counted twice, or missed,... Read more

Industry

view channel
Image: The TOMR trial uses Signatera-guided MRD testing to identify high-risk patients for curative-intent treatment.

Natera and Incyte Collaborate on MRD-Guided Colorectal Cancer Treatment Study

Natera (Austin, TX, USA) has entered into a clinical collaboration with Incyte (Wilmington, DE, USA) for a Phase II study evaluating molecular residual disease (MRD)-guided treatment in colorectal cancer.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.